+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer



Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer



Cancer 74(8): 2307-2313



Background: The objective of this study was to investigate the prognostic significance of serum antibodies to human papillomavirus (HPV)-16 peptides in patients with squamous cell cervical cancer. Methods: Pretreatment sera from 78 patients and 198 control women were tested by an enzyme-linked immunosorbent assay technique for reactivity with HPV-16 E4 (E401p) and E7 (E701p) synthetic peptides. The presence and serum level of these antibodies were correlated with tumor stage, histologic features. and prognostic parameters. Results: The median follow-up was 65 months (range, 6-97 months). Antibodies to E401p peptide were found in 5 of the 198 (3%) control subjects, 4 of the 43 (9%) patients with low tumor stage (International Federation of Gynecology and Obstetrics (FIGO) Ia, Ib, IIa), and 7 of the 35 (20%) patients with advanced tumor stage (FIGO IIb, III, IVa). Antibodies to E701p were found in 25 (13%), 11 (26%), and 11 (31%) women, respectively. The differences between patients and control subjects were significant (P lt 0.002). Seropositivity against these peptides showed no correlation with tumor stage. Antibody levels to both peptides were significantly higher in patients compared with control subjects (P lt 0.05). Furthermore, antibody levels to E401p were higher in patients with advanced tumor stage versus patients with low tumor stage (P = 0.0097). Such a relation was not found for anti-E701p antibodies. In the univariate analysis, a high level of anti-E701p antibodies was associated with a shorter disease free interval (P = 0.012) and poor survival (P = 0.049). However, this variable possessed no prognostic value after adjusting for FIGO stage and tumor size. Conclusions: The authors' findings indicate that the prognostic significance of serum antibodies to the HPV-16 E4 and E7 peptides used in this study of patients with cervical cancer is limited.

(PDF emailed within 0-6 h: $19.90)

Accession: 009254684

Download citation: RISBibTeXText

PMID: 7922982

DOI: 10.1002/1097-0142(19941015)74:8<2307::aid-cncr2820740815>3.0.co;2-x


Related references

Poster Prognostic Significance of Human Papillomavirus Dna Finding in Primary Cervical Cancer and Pelvic Lymph Nodes in Cervical Cancer Patients. European Journal of Cancer 47: S534-S535, 2011

Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecologic Oncology 29(3): 267-273, 1988

Prognostic significance of human papillomavirus type 16 and 18 in cervical cancer. Seoul Journal of Medicine 36(2): 53-60, 1995

Clinical significance of serum anti-human papillomavirus 16 and 18 antibodies in cervical neoplasia. Obstetrics and Gynecology 121(2 Pt 1): 321-329, 2013

Clinical Significance of Serum Anti-Human Papillomavirus 16 and 18 Antibodies in Cervical Neoplasia. Obstetrics & Gynecology 121(2, Part 1): 321-329, 2013

Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients. Gynecologic Oncology 85(2): 333-338, 2002

Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens. American Journal Of Obstetrics & Gynecology. 174(3): 937-942, 1996

Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer. Cancer Medicine 7(11): 5655-5664, 2018

Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer. Journal of Clinical Oncology 15(2): 610-619, 1997

Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancer. American Journal of Obstetrics & Gynecology 186(4): 705-711, 2002

Prognostic significance of human papillomavirus detected with polymerase chain reaction in cervical cancer. Zhonghua Yi Xue Za Zhi 51(2): 97-102, 1993

Prognostic significance of human papillomavirus (HPV) type and nuclear DNA content in invasive cervical cancer. International Journal of Gynecological Cancer 1(2): 59-67, 1991

Occurrence of IgA and IgG antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls. Cancer Research 50(24): 7815-7819, 1990

Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls. Journal of Infectious Diseases 170(6): 1424-1431, 1994

Detection of human papillomavirus DNA, serum p53, and p53 antibodies in patients with cervical cancer. Journal of Environmental Pathology, Toxicology and Oncology 21(1): 79-85, 2002